# Assessment of Local Anaesthesia Effectiveness in Symptomatic Irreversible Pulpitis

> **NCT06862570** · PHASE2 · COMPLETED · sponsor: **28 Military Dental Centre Lahore** · enrollment: 123 (actual)

## Conditions studied

- Symptomatic Irreversible Pulpitis

## Interventions

- **DRUG:** 2% lignocaine with epinephrine 1.8 ml(36mg/ml lignocaine HCL, epinephrine bitartrate 0.0324mg/ml)
- **DRUG:** 4% Articaine with epinephrine 1.7 ml (40mg/ml Articaine HCL, epinephrine bitartrate 0.018 mg/ml)

## Key facts

- **NCT ID:** NCT06862570
- **Lead sponsor:** 28 Military Dental Centre Lahore
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-19
- **Primary completion:** 2023-05-19
- **Final completion:** 2023-05-19
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06862570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06862570, "Assessment of Local Anaesthesia Effectiveness in Symptomatic Irreversible Pulpitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06862570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*